ArticleProceedings of the National Academy of Sciences of the United States of America2023

CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors.

Haojian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.